• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Test Strip Market

    ID: MRFR/MED/18506-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    US Test Strip Market Research Report By Product Type (Urine Test Strip, Diabetic Strips, Fluorescein), By Application (Disease Diagnosis, Pregnancy Test), By Function (Visual Test Strips, Automated Test Strips) and By End User (Institutes & Research Laboratories, Hospital & Clinics, Diagnostic Laboratories) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Test Strip Market Infographic
    Purchase Options

    US Test Strip Market Summary

    The US Test Strip market is projected to grow from 1.6 USD Billion in 2024 to 3.5 USD Billion by 2035.

    Key Market Trends & Highlights

    US Test Strip Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 7.38 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 3.5 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 1.6 USD Billion, reflecting a strong foundation for future expansion.
    • Growing adoption of advanced diagnostic technologies due to increasing prevalence of chronic diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.6 (USD Billion)
    2035 Market Size 3.5 (USD Billion)
    CAGR (2025-2035) 7.38%

    Major Players

    Siemens Healthineers, Glucorelish, Acon Laboratories, HoffmannLa Roche, Roche, Nova Biomedical, HTC Health, Bayer, Caresens, Abbott Laboratories, Ascensia Diabetes Care, Optimum Health, Medtronic, Dexcom, LifeScan

    US Test Strip Market Trends

    The US Test Strip Market is experiencing significant trends driven by the increasing prevalence of diabetes and the need for effective monitoring solutions. The rise in lifestyle-related conditions and aging population contribute to a growing demand for test strips, particularly as more individuals are diagnosed with diabetes.

    Furthermore, technological advancements, such as the development of smart-test strips that integrate with mobile applications, are changing the landscape of blood glucose monitoring, offering more convenient and accurate ways to track health. Opportunities in the US market include the expansion of home healthcare and point-of-care testing.

    As patients increasingly prefer convenience and remote health monitoring, manufacturers are encouraged to innovate and enhance their product offerings. The potential for collaboration between test strip manufacturers and technology companies also remains substantial, as this could lead to improved data management and user experience.

    Recent times have witnessed trends emerging from regulatory changes as well. The Food and Drug Administration has introduced measures to streamline the approval process for digital health devices, including blood glucose monitors and associated test strips. This creates an avenue for new entrants into the market, fostering competition and innovation. Additionally, there is a growing emphasis on affordability and accessibility of diabetes management tools in the United States, reflecting the healthcare system's push towards reducing costs for patients.

    As awareness regarding diabetes management continues to rise, the need for better access to testing supplies and supportive technology will remain prevalent in the evolving US Test Strip Market.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Market Segment Insights

    Test Strip Market Product Type Insights

    The US Test Strip Market is experiencing significant evolution, particularly in the product type segment, which encompasses a variety of test strips including Urine Test Strips, Diabetic Strips, and Fluorescein strips. Each of these types plays a vital role in healthcare, contributing to the overall market growth and advancement in diagnostics.

    Meanwhile, Diabetic Strips dominate the market, driven by the increasing incidence of diabetes across the United States. With over 34 million Americans diagnosed with diabetes, the demand for reliable blood glucose monitoring tools such as diabetic strips has surged in recent years. This segment’s importance cannot be overstated, as it contributes to effective diabetes management and is crucial for preventing complications associated with the disease.

    Fluorescein strips, although less common than the previously mentioned types, hold significant value particularly in the ophthalmic space. Their application in detecting corneal abrasions and other eye conditions has made them indispensable within healthcare settings. The focus on improving patient outcomes continues to drive innovation and enhancements within this segment. Notably, the US Test Strip Market revenue is underpinned by technological advancements that streamline the manufacturing process and lead to more accurate results.

    Overall, market growth in this segment can be attributed to the rising awareness of preventative healthcare, the proliferation of chronic diseases, and active initiatives aimed at facilitating self-monitoring among patients. The healthcare industry in the US is increasingly prioritizing point-of-care testing solutions, highlighting the critical importance of these product types in meeting the diverse needs of patients and healthcare providers alike. As a result, the US Test Strip Market statistics reflect a dynamic and competitive landscape where the need for efficiency and accuracy drives ongoing innovations and product diversification.

    Test Strip Market Application Insights

    The Application segment of the US Test Strip Market plays a crucial role in the healthcare landscape, particularly in areas such as Disease Diagnosis and Pregnancy Testing. The Disease Diagnosis category has gained significant attention due to the increasing prevalence of chronic diseases, prompting swift advancements in point-of-care testing.

    These Tests are generally favored for their ease of use and rapid results, making them a preferred choice among consumers. The US Test Strip Market segmentation reflects a clear trend towards convenience and immediate results, aligning with patients' increasing expectations for timely healthcare interventions. Factors such as technological innovations alongside the expansion of healthcare services are likely to drive growth in these applications, while challenges may arise from regulatory hurdles and the need for continuous improvement in test accuracy and reliability, particularly in the context of Disease Diagnosis.

    Overall, these segments are critical to understanding the dynamics of the market and the ongoing shifts in consumer behavior as it adapts to evolving healthcare demands.

    Test Strip Market Function Insights

    The Function segment of the US Test Strip Market plays a critical role in the healthcare landscape, particularly for individuals managing diabetes and other chronic conditions. The market is increasingly divided into two main categories Visual Test Strips and Automated Test Strips.

    The growing awareness of diabetes and the increasing prevalence of metabolic disorders in the US significantly contribute to the market growth. Moreover, the ongoing advancements in technology are expected to enhance the functionality of automated testing, further driving demand. Challenges such as market saturation and regulatory hurdles must be navigated, but ample opportunities exist for innovation and expansion within the Function segment as the US healthcare system increasingly focuses on personalized medicine and patient-centric care approaches.

    Test Strip Market End User Insights

    The End User segment of the US Test Strip Market is critical in shaping the market's dynamics, with key players including Institutes and Research Laboratories, Hospitals and Clinics, and Diagnostic Laboratories. Hospitals and Clinics represent a significant portion of the market, as they require test strips for immediate patient care and routine health monitoring.

    Overall, the interdependence of these sectors showcases their significance in health care delivery and medical advancements in the US, where the demand for reliable and efficient testing continues to grow in response to evolving health challenges. The insights pertaining to the End User segment reflect essential trends in the US Test Strip Market, including the increasing emphasis on rapid diagnostics and home monitoring solutions.

    Get more detailed insights about US Test Strip Market

    Key Players and Competitive Insights

    The US Test Strip Market is characterized by a dynamic environment with several key players striving to establish strong competitive advantages through innovation, quality, and regulatory compliance. The industry focuses on the production and distribution of test strips primarily for diabetes management, urinalysis, and other diagnostic purposes. The market has been driven by the rising prevalence of chronic diseases, increased health awareness among consumers, and advancements in technology that have made test strips more user-friendly and efficient.

    Competitive insights reveal a landscape where companies not only compete on product efficacy but also on accessibility, pricing strategies, and the ability to offer comprehensive health monitoring solutions. Collaborations and partnerships among healthcare providers, technology firms, and research institutions are also becoming increasingly common as businesses seek to enhance their market presence and respond to consumer needs.

    Siemens Healthineers stands as a prominent player in the US Test Strip Market, leveraging its strong brand reputation and expertise in medical technology to provide innovative diagnostic solutions. The company’s strengths lie in its commitment to research and development, ensuring that it remains at the forefront of technological advancements in testing. Siemens Healthineers is recognized for its high-quality test strips that deliver accurate and reliable results, thereby enhancing patient outcomes. The company's extensive experience in the healthcare sector enhances its capability to navigate regulatory challenges effectively and establish strong distribution networks across the United States.

    Additionally, Siemens Healthineers invests heavily in training healthcare professionals to maximize the efficacy of its diagnostic tests, which further strengthens its market position.

    Glucorelish, another key competitor in the US Test Strip Market, specializes in developing and manufacturing test strips specifically designed for glucose monitoring in diabetic patients. The company’s product portfolio includes a range of affordable and easy-to-use test strips that align with current consumer expectations for convenience and efficiency. Glucorelish has established a significant market presence through strategic partnerships and an emphasis on customer service, ensuring that products are accessible to a larger demographic. The company’s strengths include a strong focus on innovation, which has led to the development of advanced testing solutions that minimize errors and enhance user experience.

    Furthermore, Glucorelish has pursued various mergers and acquisitions to expand its capabilities and product offerings in the US market, solidifying its position as a trusted provider of essential diagnostic tools in the diabetes care sector.

    Key Companies in the US Test Strip Market market include

    Industry Developments

    In recent months, notable developments in the US Test Strip Market have emerged, reflecting the growth and ongoing innovation within the industry. Siemens Healthineers has expanded its product portfolio, launching new glucose test strips aimed at enhancing user experience and accuracy. Meanwhile, Abbott Laboratories is witnessing significant growth in its FreeStyle line of diabetic test strips, further solidifying its position in the market.

    The demand for innovative solutions in diabetes management continues to drive partnerships, with Acon Laboratories announcing collaborations to improve distribution efficiency. In terms of mergers and acquisitions, F. Hoffmann-La Roche has been active, acquiring a smaller biotech company in September 2023 to bolster its diabetes care capabilities. This acquisition aligns with the growing trend towards integrated health solutions within the diabetes management sector.

    Another significant event occurred in June 2022 when Medtronic expanded its partnership with Dexcom, focusing on advancing continuous glucose monitoring technology. The US Test Strip Market's valuation is positively influenced by increasing investments in Research and Development, with companies such as Nova Biomedical and Ascensia Diabetes Care leading the innovation charge, further stating the market's potential for growth in the coming years.

    Market Segmentation

    Test Strip Market End User Outlook

    • Institutes & Research Laboratories
    • Hospital & Clinics
    • Diagnostic Laboratories

    Test Strip Market Function Outlook

    • Visual Test Strips
    • Automated Test Strips

    Test Strip Market Application Outlook

    • Disease Diagnosis
    • Pregnancy Test

    Test Strip Market Product Type Outlook

    • Urine Test Strip
    • Diabetic Strips
    • Fluorescein

    FAQs

    What is the expected market size of the US Test Strip Market in 2024?

    The US Test Strip Market is expected to be valued at 1.6 billion USD in 2024.

    What is the projected market value of the US Test Strip Market in 2035?

    The market is projected to reach a value of 3.5 billion USD by 2035.

    What is the expected CAGR for the US Test Strip Market from 2025 to 2035?

    The expected CAGR for the US Test Strip Market from 2025 to 2035 is 7.375%.

    How much is the Urine Test Strip segment expected to be worth in 2035?

    The Urine Test Strip segment is expected to be valued at 1.32 billion USD in 2035.

    What is the projected market value of Diabetic Strips in 2024?

    Diabetic Strips are projected to be valued at 0.72 billion USD in 2024.

    What are the key competitors in the US Test Strip Market?

    Key competitors include Siemens Healthineers, Acon Laboratories, Roche, Abbott Laboratories, and Dexcom.

    What is the anticipated market size for Fluorescein Test Strips in 2035?

    The Fluorescein Test Strips segment is anticipated to be worth 0.49 billion USD by 2035.

    What opportunities exist for growth in the US Test Strip Market?

    Opportunities for growth include advancements in technology and increasing global health awareness.

    What challenges might impact the US Test Strip Market in the coming years?

    Challenges may include regulatory hurdles and market competition affecting profit margins.

    How does the regional market size for the US Test Strip Market compare globally?

    The US Test Strip Market is among the largest in the world, driven by high healthcare expenditure and innovation.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials